| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 3, 2006
Accepted on September 11, 2006
Prince Henry’s Institute of Medical Research, P.O. Box 5152, Clayton, Victoria 3168, Australia, Dept. of Anatomy and Cell Biology and Dept. of Biochemistry, Monash University, Clayton, Victoria, Australia
* To whom correspondence should be addressed. E-mail: kerry.mcinnes{at}princehenrys.org.
Menopause is associated with an accumulation of visceral fat. An emerging concept suggests that relatively elevated levels of circulating androgens compared with estrogens in post-menopausal women underlie this shift in body-fat distribution. In this study we administered dihydrotestosterone (DHT) to ovariectomised (ovx) mice to examine the effect of relative androgen excess on adipose tissue distribution and function in estrogen-deficient mice. Compared with controls, DHT-treated mice exhibited increased body weight and visceral fat mass associated with triglyceride accumulation. Phosphorylation of AMP-activated-protein-kinase (AMPK) and Acetyl-CoA-Carboxylase (ACC) was significantly decreased by DHT in visceral fat. In 3T3-L1 cells, DHT decreased phosphorylation of AMPK in a dose-dependent manner. In addition, DHT increased the expression of lipogenic genes (Fatty-Acid-Synthase, Sterol Regulatory Element Binding Protein-2 and Lipoprotein Lipase) in visceral fat. These data provide the first in vivo evidence that an increased androgen-estrogen ratio can promote visceral fat accumulation by inhibiting AMPK activation and stimulating lipogenesis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |